John H Johnson Insider Trading $SCMP Sucampo Pharmaceuticals, Inc.
Get free email notifications about insider trading for John H Johnson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John H Johnson. John H Johnson is CEO in IMCLONE SYSTEMS INC ($IMCLE) and Director in PORTOLA PHARMACEUTICALS INC ($PTLA) and Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in HISTOGENICS CORP ($HSGX) and Chief Executive Officer in MELINTA THERAPEUTICS, INC. /NEW/ ($MLNT) and Director in CEMPRA, INC. ($CEMP) and Interim CEO in MELINTA THERAPEUTICS, INC. /NEW/ ($MLNT) and Director in Verastem, Inc. ($VSTM) and Chief Executive Officer in Strongbridge Biopharma plc ($SBBP) and Director in Strongbridge Biopharma plc ($SBBP) and Executive Chairman in Strongbridge Biopharma plc ($SBBP).
John H Johnson in Sucampo Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John H Johnson: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 13 2018
$SCMP Market Capitalization: $496.69M
$SCMP Previous Close: $11.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John H Johnson in Sucampo Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVEO, IMCLE, MLNT, HSGX, PTLA, SBBP, SCMP, VSTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Option Exercise | D | 10.30 | 10,000 | 103,000 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Option Exercise | D | 16.23 | 20,000 | 324,600 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Option Exercise | D | 13.92 | 30,000 | 417,600 | 0 | |
| Feb 13 2018 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Sell | D | 18.00 | 5,130 | 92,340 | 0 | 5.1 K to 0 (-100.00 %) |
| Jun 05 2017 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Option Exercise | A | 10.30 | 10,000 | 103,000 | 60,000 | |
| Jun 05 2017 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 5,130 | 0 | 14,930 | 9.8 K to 14.9 K (+52.35 %) |
| Jun 06 2016 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Grant | A | 0.00 | 9,800 | 0 | 9,800 | 0 to 9.8 K |
| Jun 02 2015 | SCMP | Sucampo Pharmaceut ... | JOHNSON JOHN | Director | Option Exercise | A | 16.23 | 20,000 | 324,600 | 50,000 |
Page: 1